Rheumatology: COVID-19 implications for lungs & fibrosis - parallels with diffuse systemic sclerosis Ver más
Recorded on 20 May 2020, as part of The Royal Society of Medicine's events programme.
Organised by the Rheumatology & Rehabilitation Section.
Rheumatologists have been surprised by the presentations and potential parallels with autoimmune diseases and systemic sclerosis (SSc). Professor Denton, a global expert in systematic sclerosis, has been working on the frontline in COVID-19 care at the Royal Free Hospital in London, and Dr Stephanie Kaye-Barrett, Consultant Physician and Rheumatologist, here talk about the parallel aspects of autoimmune diseases, systemic sclerosis and COVID-19.
Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic
See all upcoming RSM events: https://rsm.ac/3kHR00T
Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU
Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE
Rheumatology & Rehabilitation: Common therapeutic pathways - the cytokine storm in COVID-19 Ver más
Recorded on 4 May 2020, as part of The Royal Society of Medicine's events programme.
Organised by the Rheumatology & Rehabilitation Section.
Dr Jessica Manson, Consultant Rheumatologist at UCLH and Dr Stephanie Kaye-Barrett, Consultant Physician and Rheumatologist, discuss cytokine storms and how they are a common complication, not only of COVID-19 and flu, but also other respiratory diseases caused by coronaviruses such as SARS and MERS.
Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic
See all upcoming RSM events: https://rsm.ac/3kHR00T
Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU
Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE
Rheumatology and Rehabilitation: COVID-19 and the use of rheumatology drugs Ver más
Recorded on 29 April 2020, as part of The Royal Society of Medicine's events programme.
Organised by the Rheumatology & Rehabilitation Section.
Recently a number of drugs, which have been used in rheumatology for decades, have been found to be beneficial in the various stages of COVID-19, according to case reports and limited studies. This webinar looks at the evidence behind these reports and studies, and the new trials which will involve the use of these drugs.
Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic
See all upcoming RSM events: https://rsm.ac/3kHR00T
Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU
Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE